<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="93982">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01881425</url>
  </required_header>
  <id_info>
    <org_study_id>INN005</org_study_id>
    <nct_id>NCT01881425</nct_id>
  </id_info>
  <brief_title>InnFocus MicroShunt Versus Trabeculectomy Study</brief_title>
  <acronym>IMS</acronym>
  <official_title>A Randomized Study Comparing the Safety and Efficacy of the InnFocus MicroShuntTM Glaucoma Drainage System to Standard Trabeculectomy In Subjects With Primary Open Angle Glaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>InnFocus Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>InnFocus Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assess the safety and effectiveness of the InnFocus MicroShunt when used to lower
      intraocular pressure (IOP) in subjects with primary open angle glaucoma where the IOP is not
      controlled when using maximum tolerated glaucoma medications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This clinical trial is a prospective, randomized, controlled, multicenter, study. After
      informed consent is obtained, patients will be evaluated for eligibility based on glaucoma
      severity, eye health, and visual acuity.

      Clinical follow up will be scheduled over the course of the 24 month study, and examinations
      will be repeated to monitor eye health. At the 1 and 2 year follow up, diurnal (IOP taken in
      the morning, mid-day, and afternoon in the same day) IOP evaluation will be done. Annual
      follow up will occur up to 2 years. The primary effectiveness endpoint is 20% or greater
      reduction in IOP from pre-op medicated IOP at 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>&gt; 20% decrease in diurnal intraocular pressure</measure>
    <time_frame>1 year</time_frame>
    <description>The primary effectiveness outcome is &gt; 20% IOP reduction from baseline to 12 months follow-up.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction in diurnal intraocular pressure</measure>
    <time_frame>1 year</time_frame>
    <description>The secondary effectiveness outcome is the reduction in diurnal intraocular pressure from baseline to 12 months post-operative examination.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">857</enrollment>
  <condition>Primary Open Angle Glaucoma</condition>
  <arm_group>
    <arm_group_label>InnFocus MicroShunt</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>InnFocus MicroShunt</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Trabeculectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>glaucoma surgery to reduce IOP</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Glaucoma Surgery</intervention_name>
    <description>An initial pocket is created under the conjunctiva and Tenon's capsule and the wound bed is treated for two minutes with mitomycin C (MMC, 0.2 mg/ml)soaked sponges. This is done using a &quot;fornix-based&quot; conjunctival incision at the corneoscleral junction. A partial thickness scleral flap with its base at the corneoscleral junction after cauterization of the flap area, and a window opening is created under the flap with a Kelly-punch to remove a portion of the sclera, Schlemm's canal and the trabecular meshwork to enter the anterior chamber. An iridectomy is done in many cases to prevent future blockage of the sclerostomy. The scleral flap is then sutured loosely back in place with several sutures. The conjunctiva is closed in a watertight fashion at the end of the procedure.</description>
    <arm_group_label>Trabeculectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>InnFocus MicroShunt</intervention_name>
    <description>An initial pocket is created under the conjunctiva and Tenon's capsule and the wound bed is treated for two minutes with mitomycin C (MMC, 0.2 mg/ml)soaked sponges. This is done using a &quot;fornix-based&quot; conjunctival incision at the corneoscleral junction. After cauterization of the flap area, a knife is used to create a shallow pocket at the scleral surface and an opening into the AC. The device is then threaded through the track until the proximal end is in the anterior chamber and the fin of the device is pushed into the shallow scleral pocket. The device is checked to observe aqueous flow and the distal end placed under the Tenons/conjunctiva. The conjunctiva is closed in a watertight fashion at the end of the procedure.</description>
    <arm_group_label>InnFocus MicroShunt</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: - POAG on maximum tolerated glaucoma meds - Medicated ≥15mmHg and
        ≤40mmHg - Exclusion Criteria: - Previous conjunctival incisional ophthalmic surgery -
        Anticipated need for additional ocular surgery during the study - Secondary glaucoma - Any
        condition that prevents the device implantation or trabeculectomy in the superior region
        of the study eye
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Palmberg, M.D., Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Bascom Palmer Eye Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Haydee Frost, CCRC</last_name>
    <phone>305-378-2651</phone>
    <phone_ext>246</phone_ext>
    <email>hfrost@innfocusinc.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Eye Physicians and Surgeons of Arizona</name>
      <address>
        <city>Glendale</city>
        <state>Arizona</state>
        <zip>85306</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pat Dawson</last_name>
      <email>pat@reissmd.com</email>
    </contact>
    <contact_backup>
      <last_name>George Reiss, MD</last_name>
      <email>iceskte@aol.com</email>
    </contact_backup>
    <investigator>
      <last_name>George Reiss, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arizona Eye Consultants</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corin Kew</last_name>
      <phone>520-327-3487</phone>
      <email>corinkew@email.arizona.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jason Levine, M.D.</last_name>
      <phone>520-327-3487</phone>
    </contact_backup>
    <investigator>
      <last_name>Jason Levine, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vold Vision</name>
      <address>
        <city>Fayetteville</city>
        <state>Arkansas</state>
        <zip>72704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corinna Rose</last_name>
      <phone>479-442-8653</phone>
      <email>crose@voldvision.com</email>
    </contact>
    <contact_backup>
      <last_name>Steven Vold, M.D.</last_name>
      <phone>479-442-8653</phone>
      <email>svold@voldvision.com</email>
    </contact_backup>
    <investigator>
      <last_name>Steven Vold, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California at Davis Eye Center</name>
      <address>
        <city>Davis</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marisa Salvador</last_name>
      <email>mesalvador@ucdavis.edu</email>
    </contact>
    <contact_backup>
      <last_name>Michelle Lim, MD</last_name>
      <email>mclim@ucdavis.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Michelle Lim, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UCLA Jules Stein Eye Institute</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diane Ngo</last_name>
      <email>d.ngo@jsei.ucla.edu</email>
    </contact>
    <contact_backup>
      <last_name>Joseph Caprioli</last_name>
      <email>Caprioli@jsei.ucla.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Joseph Caprioli, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ophthalmic Consultants of Connecticut</name>
      <address>
        <city>Fairfield</city>
        <state>Connecticut</state>
        <zip>06824</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Gonyea</last_name>
      <phone>203-237-1818</phone>
      <email>mgonyea@occeye.com</email>
    </contact>
    <contact_backup>
      <last_name>Robert Noecker, M.D.</last_name>
      <phone>203-366-8000</phone>
    </contact_backup>
    <investigator>
      <last_name>Robert Noecker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inter-Mountain Eye Care</name>
      <address>
        <city>Eagle</city>
        <state>Idaho</state>
        <zip>83616</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jill Heinz</last_name>
      <phone>208-841-8624</phone>
      <email>jill.tvcr@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Adam Reynolds, M.D.</last_name>
      <phone>208-918-4712</phone>
    </contact_backup>
    <investigator>
      <last_name>Adam Reynolds, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chicago Glaucoma Consultants and CGC Eye Center</name>
      <address>
        <city>Glenview</city>
        <state>Illinois</state>
        <zip>60026</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Kesten</last_name>
      <email>wms13@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Steven Brown, MD</last_name>
      <email>drsvib@aol.com</email>
    </contact_backup>
    <investigator>
      <last_name>Steven Brown, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eugene and Marilyn Glick Eye Institute</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46290</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Morgan</last_name>
      <phone>317-814-2745</phone>
      <email>lismorga@iupui.edu</email>
    </contact>
    <investigator>
      <last_name>Louis Cantor, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stiles Eyecare Excellence</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Punjabi</last_name>
      <phone>913-681-1601</phone>
      <email>jpunjabi@stileseye.com</email>
    </contact>
    <contact_backup>
      <last_name>Michael Stiles, M.D.</last_name>
      <phone>(913) 897-9299</phone>
    </contact_backup>
    <investigator>
      <last_name>Michael Stiles, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington Eye Physicians and Surgeons</name>
      <address>
        <city>Chevy Chase</city>
        <state>Maryland</state>
        <zip>20815</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Minnesota Eye Consultants, PA</name>
      <address>
        <city>Bloomington</city>
        <state>Minnesota</state>
        <zip>55431</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danielle Vitali</last_name>
      <email>dnvitali@mneye.com</email>
    </contact>
    <contact_backup>
      <last_name>Christine Larsen, MD</last_name>
      <email>cllarsen@mneye.com</email>
    </contact_backup>
    <investigator>
      <last_name>Christine Larsen, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Midwest Eye Surgery Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virginia Keenan</last_name>
      <email>vkeenan@midwesteyecare.com</email>
    </contact>
    <contact_backup>
      <last_name>Martin Mizener, MD</last_name>
      <email>mmizener@midwesteyecare.com</email>
    </contact_backup>
    <investigator>
      <last_name>Martin Mizener, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York Eye and Ear Infirmary of Mt. Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meliza Unson</last_name>
      <email>munson@nyee.edu</email>
    </contact>
    <contact_backup>
      <last_name>Joseph Panarelli, MD</last_name>
      <email>joepanarelli@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Joseph Panarelli, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Glaucoma Consultants of the Capital Region</name>
      <address>
        <city>Slingerlands</city>
        <state>New York</state>
        <zip>12159</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy Caswell</last_name>
      <phone>518-475-7300</phone>
      <email>kathy.caswell@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Steven Simmons, M.D.</last_name>
      <phone>(518) 475-7300</phone>
      <email>glaucomaconsult@aol.com</email>
    </contact_backup>
    <investigator>
      <last_name>Steven Simmons, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cincinnati Eye Institute</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Wessel</last_name>
      <phone>513-569-3682</phone>
      <email>jlwessel@CincinnatiEye.com</email>
    </contact>
    <contact_backup>
      <last_name>Anup Khatana, M.D.</last_name>
      <phone>513-569-3682</phone>
      <email>akhatana@CincinnatiEye.com</email>
    </contact_backup>
    <investigator>
      <last_name>Anup Khatana, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ophthalmic Surgeons and Consultants of Ohio</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Meadows</last_name>
      <email>teresa@ohioeyesurgeons.com</email>
    </contact>
    <contact_backup>
      <last_name>Doug Baker, MD</last_name>
      <email>bakerdoug217@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Doug Baker, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dean McGee Eye Institute</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shannon Almeida</last_name>
      <phone>405-271-6307</phone>
      <email>shannon-almeida@dmei.org</email>
    </contact>
    <contact_backup>
      <last_name>Mahmoud Khaimi, M.D.</last_name>
      <phone>405-271-6060</phone>
    </contact_backup>
    <investigator>
      <last_name>Mahmoud Khaimi, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ophthalmic Partners of Pennsylvania</name>
      <address>
        <city>Bala Cynwyd</city>
        <state>Pennsylvania</state>
        <zip>19004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cathy Petrocella</last_name>
      <phone>484-434-2706</phone>
      <email>CPetrocella@oppdoctors.com</email>
    </contact>
    <contact_backup>
      <last_name>Marlene Moster, M.D.</last_name>
      <phone>484-434-2700</phone>
      <email>marlenemoster@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Marlene Moster, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Glaucoma Associates of Texas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samantha Villa</last_name>
      <phone>214-765-9720</phone>
      <email>svilla@glaucomaassociates.com</email>
    </contact>
    <contact_backup>
      <last_name>Davinder Grover, M.D.</last_name>
      <phone>214-360-0000</phone>
      <email>dgrover@glaucomaassociates.com</email>
    </contact_backup>
    <investigator>
      <last_name>Davinder Grover, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ophthalmology Associates</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Starr, COA, CRC</last_name>
      <email>kstarr@oafw2020.com</email>
    </contact>
    <contact_backup>
      <last_name>Brian Flowers, M.D.</last_name>
      <email>bflowers@oafw2020.com</email>
    </contact_backup>
    <investigator>
      <last_name>Brian Flowers, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Robert Cizik Eye Clinic</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Baker</last_name>
      <phone>713-559-5200</phone>
      <email>LauraBaker@cizikeye.org</email>
    </contact>
    <contact_backup>
      <last_name>Robert Feldman, M.D.</last_name>
      <phone>713-559-5200</phone>
    </contact_backup>
    <investigator>
      <last_name>Robert Feldman, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rashid, Rice, Flynn and Reilley Eye Associates</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Hazen</last_name>
      <email>maggie@rreyes.net</email>
    </contact>
    <contact_backup>
      <last_name>William Flynn</last_name>
      <email>wflynn@rreyes.net</email>
    </contact_backup>
    <investigator>
      <last_name>William Flynn, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Specialty Eye Care</name>
      <address>
        <city>Bellevue</city>
        <state>Washington</state>
        <zip>98004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renee Cook</last_name>
      <phone>425-454-3937</phone>
      <email>rcook@specialtyeyecarecentre.com</email>
    </contact>
    <contact_backup>
      <last_name>Howard Barnebey, M.D.</last_name>
      <phone>(425) 454-3937</phone>
    </contact_backup>
    <investigator>
      <last_name>Howard Barneby, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 10, 2017</lastchanged_date>
  <firstreceived_date>June 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>POAG</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
